Jubilant Life Sciences Surges After Q2 Net Profit Rises

Jubilant Life Sciences Ltd is currently trading at Rs 688, up by Rs 38.7 or 5.96% from its previous closing of Rs 649.3 on the BSE. The company has posted a net profit after taxes, minority interest & share of profit / loss of associates of Rs 144.8 crore for the quarter ended September 30, 2016 as compared to Rs 126.4 crore for the quarter ended September 30, 2015. Total Income has decreased from Rs 1,496.4 crore for the quarter ended September 30, 2015 to Rs 1,424.3 crore for the quarter ended September 30, 2016.

Its sales declined 5% to Rs 1,359.7 crore in the quarter ended September 2016 as against Rs 1,433.6 crore during the previous quarter ended September 2015. The scrip opened at Rs 653.8 and has touched a high and low of Rs 698 and Rs 637.5 respectively. So far 1135465(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 10343.35 crore.

The BSE group 'A' stock of face value Rs 1 has touched a 52 week high of Rs 700.9 on 19-Oct-2016 and a 52 week low of Rs 272.5 on 20-Jan-2016. Last one week high and low of the scrip stood at Rs 697 and Rs 642.25 respectively. The promoters holding in the company stood at 54.02 % while Institutions and Non-Institutions held 26.26 % and 17.34 % respectively. The stock is currently trading above its 50 DMA.
For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6554125 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717
Share on Google Plus Share on Pinterest

About Suhani Varma

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.